SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (9036)9/2/2003 5:16:40 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
MGYN is starting to look intriguing to me at these levels as the stock reacts to their partnering revenue drying up and their predictive medicine business showing reduced growth. May still be too early, but worth keeping an eye on.

I've seen the recent article on r-flurbiprofen for AD:

pnas.org

Anyone seen any details on using this drug for prostate cancer? Anyone know anything at all about their HIV drug, which is directed towards viral budding?

Peter